C1S
Basic information
Region (hg38): 12:6988259-7071032
Links
Phenotypes
GenCC
Source:
- Ehlers-Danlos syndrome, periodontal type 1 (Moderate), mode of inheritance: AD
- Ehlers-Danlos syndrome, periodontal type 2 (Strong), mode of inheritance: AD
- complement component C1s deficiency (Strong), mode of inheritance: AR
- Ehlers-Danlos syndrome, periodontal type 2 (Limited), mode of inheritance: AD
- Ehlers-Danlos syndrome, periodontitis type (Supportive), mode of inheritance: AD
- complement component C1s deficiency (Strong), mode of inheritance: AR
- Ehlers-Danlos syndrome, periodontal type 2 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Ehlers-Danlos syndrome, periodontal type 2; Complement component C1s deficiency | AD/AR | Allergy/Immunology/Infectious; Cardiovascular; Gastrointestinal; Oncologic | Ehlers-Danlos syndrome, periodontal type has been described as inolving risk of arterial and gastrointestinal rupture as well as recurrent infections, and awareness may allow prompt diagnosis and management; Individuals with Ehlers-Danlos syndrome, periodontal have been described with Wilms tumor (as well as other types of neoplasms), and awareness may allow early detection and treatment; Individuals with Complement component C1s deficiency may suffer from conditions such as severe infections, for which prophylaxis and/or early and aggressive treatment of infection may be beneficial; Immunosuppression may be beneficial for autoimmune phenomena (such as lupus nephritis) | Allergy/Immunology/Infectious; Dental; Dermatologic; Musculoskeletal; Oncologic; Renal | 9856483; 9973493; 11390518; 19155518; 20191570; 27745832 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (17 variants)
- Ehlers-Danlos syndrome, periodontal type 1 (2 variants)
- Ehlers-Danlos syndrome, periodontal type 2 (2 variants)
- Complement component C1s deficiency (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the C1S gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 98 | 105 | ||||
missense | 225 | 234 | ||||
nonsense | 8 | |||||
start loss | 0 | |||||
frameshift | 11 | 17 | ||||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 4 | |||||
splice region | 9 | 10 | 3 | 22 | ||
non coding | 43 | 20 | 70 | |||
Total | 19 | 4 | 243 | 146 | 28 |
Highest pathogenic variant AF is 0.0000263
Variants in C1S
This is a list of pathogenic ClinVar variants found in the C1S region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
12-7018351-T-C | not specified | Uncertain significance (Sep 01, 2021) | ||
12-7018373-C-A | not specified | Uncertain significance (Oct 27, 2022) | ||
12-7018381-A-G | not specified | Uncertain significance (Apr 07, 2023) | ||
12-7018412-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
12-7061914-T-C | Ehlers-Danlos syndrome, periodontal type 2 | Likely pathogenic (Nov 24, 2023) | ||
12-7061922-G-A | Uncertain significance (Dec 20, 2022) | |||
12-7061925-A-G | Likely benign (Jan 25, 2024) | |||
12-7061930-G-A | Likely benign (Nov 15, 2022) | |||
12-7062058-C-T | Benign (May 10, 2021) | |||
12-7062107-T-TA | Benign (Jun 04, 2021) | |||
12-7062270-C-CAAAAA | Benign (Jun 19, 2021) | |||
12-7062357-C-T | Benign (May 10, 2021) | |||
12-7062455-C-T | Likely benign (Dec 11, 2023) | |||
12-7062463-CTG-C | Likely benign (Nov 25, 2022) | |||
12-7062477-G-T | Uncertain significance (Sep 01, 2022) | |||
12-7062494-C-T | Uncertain significance (Jan 25, 2024) | |||
12-7062500-G-T | Likely benign (Dec 07, 2019) | |||
12-7062500-GC-TT | Uncertain significance (Jan 14, 2024) | |||
12-7062501-C-T | Inborn genetic diseases | Conflicting classifications of pathogenicity (Feb 27, 2024) | ||
12-7062503-T-C | Hereditary angioedema with normal C1Inh | not provided (Feb 01, 2020) | ||
12-7062506-G-T | Uncertain significance (Jan 25, 2023) | |||
12-7062509-T-C | Uncertain significance (Dec 20, 2022) | |||
12-7062516-A-T | Inborn genetic diseases | Uncertain significance (Dec 27, 2023) | ||
12-7062517-G-A | Likely benign (Feb 10, 2022) | |||
12-7062523-C-A | Likely benign (Sep 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
C1S | protein_coding | protein_coding | ENST00000406697 | 11 | 81986 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.000677 | 0.999 | 125722 | 0 | 26 | 125748 | 0.000103 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.559 | 342 | 372 | 0.918 | 0.0000206 | 4527 |
Missense in Polyphen | 100 | 136.19 | 0.73429 | 1735 | ||
Synonymous | -0.392 | 144 | 138 | 1.04 | 0.00000779 | 1318 |
Loss of Function | 3.28 | 11 | 30.5 | 0.360 | 0.00000164 | 381 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000337 | 0.000337 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.0000544 | 0.0000544 |
Finnish | 0.0000924 | 0.0000924 |
European (Non-Finnish) | 0.000123 | 0.000123 |
Middle Eastern | 0.0000544 | 0.0000544 |
South Asian | 0.0000653 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: C1s B chain is a serine protease that combines with C1q and C1r to form C1, the first component of the classical pathway of the complement system. C1r activates C1s so that it can, in turn, activate C2 and C4.;
- Disease
- DISEASE: Complement component C1s deficiency (C1SD) [MIM:613783]: A rare defect resulting in C1 deficiency and impaired activation of the complement classical pathway. C1 deficiency generally leads to severe immune complex disease with features of systemic lupus erythematosus and glomerulonephritis. {ECO:0000269|PubMed:11390518}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Ehlers-Danlos syndrome, periodontal type, 2 (EDSPD2) [MIM:617174]: A form of Ehlers-Danlos syndrome, a connective tissue disorder characterized by hyperextensible skin, atrophic cutaneous scars due to tissue fragility and joint hyperlaxity. EDSPD2 is characterized by the association of typical features of Ehlers-Danlos syndrome with gingival recession and severe early- onset periodontal disease, leading to premature loss of permanent teeth. EDSPD2 transmission pattern is consistent with autosomal dominant inheritance. {ECO:0000269|PubMed:27745832}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Complement and coagulation cascades - Homo sapiens (human);Pertussis - Homo sapiens (human);Systemic lupus erythematosus - Homo sapiens (human);Staphylococcus aureus infection - Homo sapiens (human);Human Complement System;Dengue-2 Interactions with Complement and Coagulation Cascades;Oxidative Damage;Complement Activation;Complement and Coagulation Cascades;classical complement pathway;Innate Immune System;Immune System;Initial triggering of complement;Classical antibody-mediated complement activation;Regulation of Complement cascade;Creation of C4 and C2 activators;Complement cascade
(Consensus)
Recessive Scores
- pRec
- 0.443
Intolerance Scores
- loftool
- 0.189
- rvis_EVS
- -0.04
- rvis_percentile_EVS
- 50.45
Haploinsufficiency Scores
- pHI
- 0.190
- hipred
- N
- hipred_score
- 0.222
- ghis
- 0.526
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.935
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- C1s2
- Phenotype
Gene ontology
- Biological process
- proteolysis;complement activation;complement activation, classical pathway;regulation of complement activation;innate immune response
- Cellular component
- extracellular region;extracellular space;blood microparticle
- Molecular function
- serine-type endopeptidase activity;calcium ion binding;protein binding;identical protein binding